Skip to main content
©Philippe-Voisin & PremUp

Support the PremUp Foundation for two more years

for its research on the lungs of preterm infants

Every year, 4000 very preterm infants suffer from broncho-pulmonary dysplasia, a chronic respiratory illness. The anti-inflammatory medication currently used for this ailment in neonatology departments has serious side effects, especially from a neurological point of view.

Renew of Air Liquide Foundation support

In the context of its work on protecting the lungs of preterm infants, the PremUp Foundation has created a program to identify the inflammatory mechanisms that cause this pathology and to develop new treatments to fight this illness.

This project, whose leader is Professor Pierre-Henri Jarreau, head of the neonatology department at the Cochin Port-Royal Hospital in Paris, will once again benefit from the financial support of the Air Liquide Foundation, which will donate a total of €120,000 for 2012 and 2013.

This fundamental and clinical research, led by Elodie Zana-Taïeb, the former Senior Registrar for the neonatal medicine and reanimation department of the Cochin Port-Royal Hospital, should result in a greater understanding of the physiological mechanisms of broncho-pulmonary dysplasia and lead to the development of new adapted therapies.

This work carries on from an initial research programme supported in 2009 by the Air Liquide Foundation with €50,000 funding. The study aimed, in particular, to understand some of the inflammatory mechanisms that lead to broncho-pulmonary dysplasia in very preterm infants and to find new therapies by testing a new class of anti-inflammatory agents.

Awarded at the Air Liquide Foundation Awards 2016

This innovative project earned the PremUp Foundation the Air Liquide Award for scientific research on health and respiration in 2016.

The 2016 Air Liquide Foundation Awards: interview of Dr. Daniele Evain-Brion, PremUp Foundation

The PremUp foundation

Created in 2007 and supported by the ministries of research, healthcare and social affairs, the PremUp Foundation for scientific cooperation brings together a network of research and caregiver teams that are devoted to the protection of pregnant women, the prevention of premature births and the treatment of its complicationswww.premup.org

PROJECT IDENTITY

  • Project initiator: Fondation PremUp
  • Location: Paris, France
  • Year of support 2011
  • Air Liquide R&D Manager: Marc Lemaire, Air Liquide Healthcare International, Paris-Saclay Research Center